Tyrosine Kinase Inhibitors
Drug / Medication
A class of targeted therapy medications used to treat EGFR-driven lung cancer, which can be highly effective but resistance can develop.
Mentioned in 2 videos
Videos Mentioning Tyrosine Kinase Inhibitors
Dr. Sarah Hallberg: A personal journey through cancer | The Peter Attia Drive Podcast
Peter Attia MD
A class of targeted therapy medications used to treat EGFR-driven lung cancer, which can be highly effective but resistance can develop.
#162 - Sarah Hallberg, D.O., M.S.: Treating metabolic disease, & a personal journey through cancer
Peter Attia MD
A class of targeted therapy medications used to treat EGFR-driven cancers, effective but with a limited duration before resistance develops.